TickerFacts.

HWH International Inc. (ESYN): Cost of Revenue

Annual figures by period end, from SEC filings.

$407.2K
Year ended 2025-12-31
$651.7K2023-12-31: $334.8K2024-12-31: $651.7K2025-12-31: $407.2K$407.2K
2023-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$407.2K-37.5%2026-03-26, From 2025-01-01
2024-12-31$651.7K+94.6%2026-03-26, From 2024-01-01
2023-12-31$334.8Kn/a2025-03-31, From 2023-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Wholesale-Drugs, Proprietaries & Druggists' Sundries), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
HWH International Inc. (ESYN)2025-12-31$407.2K-37.5%
Stemtech Corp (STEK)2025-12-31$566.9K-57.3%
DataMeds AI, Inc. (MEDS)2025-12-31$29.76M+81.9%
Cosmos Health Inc. (COSM)2025-12-31$57.38M+14.5%
Nu Skin Enterprises, Inc. (NUS)2025-12-31$453.76M-17.5%
Herbalife Ltd. (HLF)2025-12-31$1.11B+0.9%
Cardinal Health Inc (CAH)2026-06-30$244.47B+14.0%
Cencora, Inc. (COR)2025-09-30$309.85B+9.1%
McKesson Corp (MCK)2026-03-31$388.88B+12.5%

Compare ESYN, STEK, MEDS, COSM side by side · Screen every company in Wholesale-Drugs, Proprietaries & Druggists' Sundries ↗